Modulation of membrane phospholipids, the cytosolic calcium influx and cell proliferation following treatment of B16-F10 cells with recombinant phospholipase-D from Loxosceles intermedia (brown spider) venom

被引:25
作者
Martins Wille, Ana Carolina [1 ,2 ]
Chaves-Moreira, Daniele [1 ]
Trevisan-Silva, Dilza [1 ]
Magnoni, Mariana Gabriel [1 ]
Boia-Ferreira, Marianna [1 ]
Gremski, Luiza Helena [1 ]
Gremski, Waldemiro [1 ,3 ]
Chaim, Olga Meiri [1 ]
Senff-Ribeiro, Andrea [1 ]
Veiga, Silvio Sanches [1 ]
机构
[1] Univ Fed Parana, Dept Cell Biol, BR-81531990 Curitiba, Parana, Brazil
[2] Univ Estadual Ponta Grossa, Dept Struct Mol Biol & Genet, Ponta Grossa, Parana, Brazil
[3] Catholic Univ Parana, Hlth & Biol Sci Inst, Curitiba, Parana, Brazil
关键词
Brown spider venom; Recombinant phospholipase-D; Membrane phospholipid modulation; Cytosolic calcium influx; Cell proliferation; GENERATES LYSOPHOSPHATIDIC ACID; D DERMONECROTIC TOXIN; SPHINGOMYELINASE-D; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; D ISOFORMS; IDENTIFICATION; ACTIVATION; PROTEIN; GROWTH;
D O I
10.1016/j.toxicon.2013.01.027
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The mechanism through which brown spiders (Loxosceles genus) cause dermonecrosis, dysregulated inflammatory responses, hemolysis and platelet aggregation, which are effects reported following spider bites, is currently attributed to the presence of phospholipase-D in the venom. In the present investigation, through two-dimensional immunoblotting, we observed immunological cross-reactivity for at least 25 spots in crude Loxosceles intermedia venom, indicating high expression levels for different isoforms of phospholipase-D. Using a recombinant phospholipase-D from the venom gland of L intermedia (LiRecDT1) in phospholipid-degrading kinetic experiments, we determined that this phospholipase-D mainly hydrolyzes synthetic sphingomyelin in a time-dependent manner, generating ceramide 1-phosphate plus choline, as well as lysophosphatidylcholine, generating lysophosphatidic acid plus choline, but exhibits little activity against phosphatidylcholine. Through immunofluorescence assays with antibodies against LiRecDT1 and using a recombinant GFP-LiRecDT1 fusion protein, we observed direct binding of LiRecDT1 to the membrane of B16-F10 cells. We determined that LiRecDT1 hydrolyzes phospholipids in detergent extracts and from ghosts of B16-F10 cells, generating choline, indicating that the enzyme can access and modulate and has activity against membrane phospholipids. Additionally, using Fluo-4, a calcium-sensitive fluorophore, it was shown that treatment of cells with phospholipase-D induced an increase in the calcium concentration in the cytoplasm, but without altering viability or causing damage to cells. Finally, based on the known endogenous activity of phospholipase-D as an inducer of cell proliferation and the fact that LiRecDT1 binds to the cell surface, hydrolyzing phospholipids to generate bioactive lipids, we employed LiRecDT1 as an exogenous source of phospholipase-D in B16-F10 cells. Treatment of the cells was effective in increasing their proliferation in a time- and concentration-dependent manner, especially in the presence of synthetic sphingomyelin in the medium. The results described herein indicate the ability of brown spider phospholipase-D to induce the generation of bioactive phospholipids, calcium influx into the cytoplasm and cell proliferation, suggesting that this molecule can be used as a bioactive tool for experimental protocols in cell biology. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:17 / 30
页数:14
相关论文
共 62 条
[1]  
Aloulou A, 2012, METHODS MOL BIOL, V861, P63, DOI 10.1007/978-1-61779-600-5_4
[2]   Lysophospholipid G protein-coupled receptors [J].
Anliker, B ;
Chun, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (20) :20555-20558
[3]  
[Anonymous], 2004, Molecular Biology of the Cell
[4]   Identification, cloning and functional characterization of a novel dermonecrotic toxin (phospholipase D) from brown spider (Loxosceles intermedia) venom [J].
Appel, Marcia Helena ;
da Silveira, Rafael Bertoni ;
Chaim, Olga Meiri ;
Paludo, Katia Sabrina ;
Silva, Dilza Trevisan ;
Chaves, Daniele M. ;
da Silva, Paulo Henrique ;
Mangili, Oldernir C. ;
Senff-Ribeiro, Andrea ;
Gremski, Waldemiro ;
Nader, Helena B. ;
Veiga, Silvio Sanches .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2008, 1780 (02) :167-178
[5]   Involvement of phospholipase D in insulin-like growth factor-I-induced activation of extracellular signal-regulated kinase, but not phosphoinositide 3-kinase or Akt, in Chinese hamster ovary cells [J].
Banno, Y ;
Takuwa, Y ;
Yamada, M ;
Takuwa, N ;
Ohguchi, K ;
Hara, A ;
Nozawa, Y .
BIOCHEMICAL JOURNAL, 2003, 369 :363-368
[6]   Sphingomyelinase D from venoms of Loxosceles spiders:: evolutionary insights from cDNA sequences and gene structure [J].
Binford, GJ ;
Cordes, MHJ ;
Wells, MA .
TOXICON, 2005, 45 (05) :547-560
[7]   Calcium Signaling [J].
Bootman, Martin D. .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2012, 4 (07) :1-3
[8]   Two new phospholipase D isoforms of Loxosceles laeta: Cloning, heterologous expression, functional characterization, and potential biotechnological application [J].
Catalan, A. ;
Cortes, W. ;
Sagua, H. ;
Gonzalez, J. ;
Araya, J. E. .
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2011, 25 (06) :393-403
[9]   Phospholipase-D activity and inflammatory response induced by brown spider dermonecrotic toxin: Endothelial cell membrane phospholipids as targets for toxicity [J].
Chaim, Olga M. ;
da Silveira, Rafael B. ;
Trevisan-Silva, Dilza ;
Ferrer, Valeria P. ;
Sade, Youssef B. ;
Boia-Ferreira, Mariana ;
Gremski, Luiza H. ;
Gremski, Waldemiro ;
Senff-Ribeiro, Andrea ;
Takahashi, Helio K. ;
Toledo, Marcos S. ;
Nader, Helena B. ;
Veiga, Silvio S. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2011, 1811 (02) :84-96
[10]   Brown spider dermonecrotic toxin directly induces nephrotoxicity [J].
Chaim, OM ;
Sade, YB ;
da Silveira, RB ;
Toma, L ;
Kalapothakis, E ;
Chávez-Olórtegui, C ;
Mangili, OC ;
Gremski, W ;
von Dietrich, CP ;
Nader, HB ;
Veiga, SS .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2006, 211 (01) :64-77